Verastem, Inc. (VSTM)
6.38
-0.27
(-4.06%)
USD |
NASDAQ |
Jan 21, 13:09
Verastem Cash from Investing (Quarterly): -8.279M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| Anavex Life Sciences Corp. | 0.00 |
| ADMA Biologics, Inc. | -14.37M |
| Ocugen, Inc. | -0.086M |
| Zevra Therapeutics, Inc. | -4.576M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -36.22M |
| Cash from Financing (Quarterly) | 17.88M |
| Free Cash Flow | -140.93M |
| Free Cash Flow Per Share (Quarterly) | -0.6082 |
| Free Cash Flow to Equity (Quarterly) | -49.26M |
| Free Cash Flow to Firm (Quarterly) | -44.18M |
| Free Cash Flow Yield | -35.33% |